Neuromuscular blocking drugs (NMBDs) play an integral role in balanced anaesthesia. They improve intubating conditions, reduce iatrogenic damage to the upper airway and decrease postoperative hoarseness.1 They also improve surgical operating conditions.2 But use of NMBDs always carries the risk of residual neuromuscular block postoperatively. About 30% of all patients who receive NMBDs intraoperatively show signs of residual neuromuscular block when arriving in the post-anaesthesia care unit.3–5 It has been suggested that residual neuromuscular block can cause postoperative pulmonary complications.6–8
http://ift.tt/2wnldJi
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου